Results 41 to 50 of about 16,398 (212)

Inflammation of actinic keratosis with combination of alkylating and taxane agents: a case report [PDF]

open access: yes, 2009
This is an Open Access article distributed under the terms of the Creative Commons Attribution ...
Fadi Makdsi, Roger DeVersa
core   +1 more source

Monitoring treatment of field cancerisation with 3% diclofenac sodium 2.5% hyaluronic acid by reflectance confocal microscopy: a histologic correlation [PDF]

open access: yes, 2017
Visual inspection may fail to accurately evaluate field cancerisation (subclinical actinic keratoses [AKs]). We aimed to describe field cancerisation by confocal reflectance microscopy and changes induced by the application of 3% diclofenac sodium gel in
Díaz Lorca, Maria Alba   +4 more
core   +1 more source

Hundred Most Cited Articles in Actinic Keratosis: A Bibliometric Analysis

open access: yesIndian Journal of Dermatology
Many articles have been published on actinic keratosis. Bibliometric analysis helps identify the most influential studies in a particular field, Our article was to identify the 100 most frequently cited references on actinic keratosis through ...
Yizhi Li   +3 more
doaj   +1 more source

German S3 guideline “actinic keratosis and cutaneous squamous cell carcinoma” – Long version of the update 2023

open access: yesEJC Skin Cancer, 2023
Actinic keratosis (AK) are common lesions in light-skinned individuals that can potentially progress to cutaneous squamous cell carcinoma (cSCC).
Ulrike Leiter   +49 more
doaj   +1 more source

Structured Expert Consensus on Actinic Keratosis:Treatment Algorithm Focusing on Daylight PDT [PDF]

open access: yes, 2017
BACKGROUND: A practical and up-to-date consensus among experts is paramount to further improve patient care in actinic keratosis (AK). OBJECTIVES: To develop a structured consensus statement on the diagnosis, classification, and practical management of ...
Claas Ulrich   +26 more
core   +3 more sources

COMPARATIVE STUDIES OF EFFICACY OF PHOTODYNAMIC THERAPY AND CRYOTHERAPY FOR TREATMENT OF ACTINIC KERATOSIS

open access: yesBiomedical Photonics, 2016
The results of a study on the effectiveness of photodynamic therapy with a photosensitizer fotoditazin and cryotherapy for actinic keratosis are represented in the article.
T. E. Sukhova   +8 more
doaj   +3 more sources

Smart Closed‐Loop Systems in Personalized Healthcare: Advances and Outlook

open access: yesAdvanced Materials Technologies, EarlyView.
A smart closed‐loop e‐textile integrates multimodal sensing, onboard processing, wireless communication, and wearable power to enable real‐time physiological/biochemical monitoring and feedback‐controlled therapy. ABSTRACT Smart textiles represent a revolutionary frontier in healthcare, seamlessly blending fabric and advanced technologies to create ...
Safoora Khosravi   +12 more
wiley   +1 more source

Evaluation of Ingenol mebutate efficacy for the treatment of actinic keratosis with Antera 3D camera [PDF]

open access: yes, 2015
OBJECTIVE: Cumulative exposure of the skin to ultraviolet radiation promotes mutation in keratinocytes and their abnormal growth led to the formation of scaly lesions, called actinic keratoses (AKs).
Bottoni, U   +5 more
core  

Pain in photodynamic therapy [PDF]

open access: yes, 2016
Photodynamic therapy is a modern treatment with applications in several medical specialties, which has been intensely studied in the last years. The main indications in dermatology are actinic keratosis, superficial basal cell carcinoma and Bowen\u27s ...
Benea, Vasile   +6 more
core   +3 more sources

Improved Systemic Immunochemotherapy Employing an Oxaliplatin‐TLR7/8 Agonist Prodrug Strategy

open access: yesAdvanced Science, EarlyView.
A platinum(IV) prodrug is developed to systemically deliver the TLR7/8 agonist gardiquimod. Tumor‐targeting is mediated by an albumin‐binding maleimide, which limits premature complex activation. Ox‐Gardi‐Mal accumulates specifically in the tumor, where it activates the immune system.
Michael Gutmann   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy